A Combination Product of Sumatriptan and Naproxen Sodium Versus Single-entity Oral Triptans: An Analysis of Real World Data

Trial Profile

A Combination Product of Sumatriptan and Naproxen Sodium Versus Single-entity Oral Triptans: An Analysis of Real World Data

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Feb 2013

At a glance

  • Drugs Naproxen sodium/sumatriptan (Primary) ; Almotriptan; Eletriptan; Frovatriptan; Naratriptan; Rizatriptan; Sumatriptan; Zolmitriptan
  • Indications Migraine
  • Focus Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 29 Jun 2011 New trial record
    • 01 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top